Genprex Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Selling, General & Admin	13.44	12.3	11.68	10.64	8.7	Upgrade
Research & Development	17.62	11.51	8.97	7.3	1.97	Upgrade
Other Operating Expenses	0.02	0.03	0.02	0.02	0.01	Upgrade
Operating Expenses	31.08	23.83	20.67	17.96	10.68	Upgrade
Operating Income	-31.08	-23.83	-20.67	-17.96	-10.68	Upgrade
Other Expense / Income	-0.22	-0.09	-0.01	-0.02	-0.03	Upgrade
Pretax Income	-30.86	-23.74	-20.66	-17.94	-10.65	Upgrade
Net Income	-30.86	-23.74	-20.66	-17.94	-10.65	Upgrade
Shares Outstanding (Basic)	1	1	1	1	0	Upgrade
Shares Outstanding (Diluted)	1	1	1	1	0	Upgrade
Shares Change	14.09%	1.82%	32.58%	121.64%	16.38%	Upgrade
EPS (Basic)	-22.56	-19.80	-17.60	-20.40	-26.40	Upgrade
EPS (Diluted)	-22.56	-19.80	-17.60	-20.40	-26.40	Upgrade
Free Cash Flow	-24.74	-17.62	-14.32	-16.16	-7.75	Upgrade
Free Cash Flow Per Share	-18.09	-14.70	-12.16	-18.20	-19.35	Upgrade
EBITDA	-30.85	-23.72	-20.64	-17.92	-10.64	Upgrade
Depreciation & Amortization	0.02	0.03	0.02	0.02	0.01	Upgrade
EBIT	-30.86	-23.74	-20.66	-17.94	-10.65	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).